HealthEquity (NASDAQ:HQY) Rating Increased to Strong-Buy at Raymond James

HealthEquity (NASDAQ:HQY) was upgraded by stock analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research note issued on Tuesday,Benzinga reports. The firm currently has a $115.00 price objective on the stock, down from their prior price objective of $120.00. Raymond James’ target price indicates a potential upside of 27.33% from the company’s current price.

HQY has been the subject of a number of other reports. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Barrington Research restated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. Finally, KeyCorp cut their target price on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $113.31.

HealthEquity Price Performance

HQY opened at $90.32 on Tuesday. The company has a fifty day moving average price of $104.67 and a two-hundred day moving average price of $95.84. The firm has a market capitalization of $7.81 billion, a PE ratio of 82.86, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently modified their holdings of the business. Arcadia Investment Management Corp MI bought a new position in HealthEquity in the fourth quarter valued at approximately $26,000. Transce3nd LLC acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $29,000. Smartleaf Asset Management LLC grew its stake in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares in the last quarter. UMB Bank n.a. increased its holdings in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ raised its position in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after acquiring an additional 445 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.